DABRAFENIB 50 MG AND 75 MG CAPSULES

GlaxoSmithKline US

Revision date : 2021-04-22

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS09
Health risk rating 4
Safety risk rating 4
Environmental risk rating 5

Note: Ingredients listed on restricted chemical lists

EC/CAS

9004-34-6

Name of the chemical

cellulose

Concentration

N/A

EC/CAS

7631-86-9

Name of the chemical

Silver adsorbed on silicon dioxide

Concentration

N/A

General Information

Revision date

2021-04-22

Product name

DABRAFENIB 50 MG AND 75 MG CAPSULES

Product Synonyms

DABRAFENIB MESYLATE, FORMULATED PRODUCT

1.2.1 Relevant identified uses

Bulk Formulated Product

Emergency telephone

VERISK 3E GLOBAL INCIDENT RESPONSE

Icons in SDS

Company Information

company name

GlaxoSmithKline US

e-mail address of the competent person responsible for the Safety Data Sheet

msds@gsk.com

GHS Information

Signal word

Warning

Section 2

Physical hazards

Not classified.

Health hazards

Carcinogenicity Category 2 Reproductive toxicity Category 2 Specific target organ toxicity, repeated Category 2 exposure

Environmental hazards

Hazardous to the aquatic environment, acute Category 1 Hazardous to the aquatic environment, Category 2

Long term hazards

OSHA defined hazards Not classified.

Signal word

Warning

Hazard statements

Suspected of causing cancer. Suspected of damaging fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure. Very toxic to aquatic life. Toxic to aquatic life with long lasting effects.

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Avoid release to the environment. Wear protective gloves/protective clothing/eye protection/face protection.

Response

If exposed or concerned: Get medical advice/attention. Collect spillage.

Storage

Store locked up.

Disposal

Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health

Classified (HNOC)

hazards.

Additional information

98.7% of the mixture consists of component(s) of unknown acute oral toxicity. 99.7% of the mixture consists of component(s) of unknown acute dermal toxicity. 66.8% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 66.8% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.